WIPI1 anticorps (C-Term)
Aperçu rapide pour WIPI1 anticorps (C-Term) (ABIN1449977)
Antigène
Voir toutes WIPI1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, Mouse, Rat.
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogène
- 17 amino acid synthetic peptide near the carboxy terminus of Human WIPI1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- WIPI1 (WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1))
-
Autre désignation
- WIPI-1
-
Sujet
- WIPI1 (WD repeat domain, phosphoinositide interacting-1), also known as WIPI1, ATG18 or WIPI49, is thought to play a role in autophagy and may regulate protein trafficking in certain recycling pathways. It contains three WD repeats and has a 7-bladed propeller structure with a conserved motif that facilitates its interaction with other proteins. WIPI1 localizes to cytoplasmic vesicles, endosomes, clathrin-coated vesicles and the trans-Golgi network. It is ubiquitously expressed with highest expression in heart, testis, placenta, pancreas and skeletal muscle. WIPI1 is upregulated in a variety of tumors, suggesting a role in carcinogenesis.Synonyms: Atg18 protein homolog, WD repeat domain phosphoinositide-interacting protein 1, WD40 repeat protein interacting with phosphoinositides of 49 kDa, WIPI1, WIPI49
-
Poids moléculaire
- 49 kDa
-
ID gène
- 55062
-
NCBI Accession
- NP_060453
-
Pathways
- Nuclear Hormone Receptor Binding, ER-Nucleus Signaling
Antigène
-